{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:24:50Z","timestamp":1794983090530,"version":"4.9.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Pyroptosis, an inflammatory form of programmed cell death, has been implicated in non-small cell lung cancer (NSCLC) progression. However, the specific pyroptosis-related genes causally linked to NSCLC and their upstream regulatory mechanisms remain poorly understood. We performed a two-sample Mendelian randomization (MR) study to assess causal relationships between 33 pyroptosis-related genes and NSCLC risk using genetic instruments from the deCODE database and outcome data from the FinnGen consortium (6446 NSCLC cases, 378,749 controls). Inverse-variance weighting was the primary analysis method, with MR-Egger, weighted median, and MR-PRESSO as sensitivity analyses. To identify upstream regulators, we integrated pQTL data from the The UK Biobank Pharma Proteomics Project and performed two-step MR mediation analysis. Identified genes were further validated using mRNA expression data from The Cancer Genome Atlas (TCGA) and genotype-tissue expression (GTEx) databases. MR analysis identified 2 pyroptosis-related genes significantly associated with NSCLC:\n                      <jats:italic toggle=\"yes\">IL1B<\/jats:italic>\n                      (odds ratio [OR]\u2005=\u20051.087, 95% confidence interval [CI]\u2005=\u20051.009\u20131.171,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.028) and\n                      <jats:italic toggle=\"yes\">PLCG1<\/jats:italic>\n                      (OR\u2005=\u20050.874, 95% CI\u2005=\u20050.766\u20130.997,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.044). Upstream analysis revealed that\n                      <jats:italic toggle=\"yes\">AMBP<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">CCNE1<\/jats:italic>\n                      were causally associated with\n                      <jats:italic toggle=\"yes\">PLCG1<\/jats:italic>\n                      expression. Mediation analysis demonstrated that\n                      <jats:italic toggle=\"yes\">PLCG1<\/jats:italic>\n                      mediated 11.7% of the total effect of\n                      <jats:italic toggle=\"yes\">AMBP<\/jats:italic>\n                      on NSCLC risk (mediation effect: OR\u2005=\u20051.02, 95% CI\u2005=\u20051.01\u20131.03,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.008). mRNA expression validation confirmed that\n                      <jats:italic toggle=\"yes\">AMBP<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">PLCG1<\/jats:italic>\n                      were significantly upregulated in NSCLC tissues compared to normal tissues (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). This study establishes causal links between pyroptosis-related genes and NSCLC, identifying\n                      <jats:italic toggle=\"yes\">IL1B<\/jats:italic>\n                      as a risk factor and\n                      <jats:italic toggle=\"yes\">PLCG1<\/jats:italic>\n                      as a protective factor. We further demonstrate that\n                      <jats:italic toggle=\"yes\">AMBP<\/jats:italic>\n                      may promote NSCLC progression partly through upregulating\n                      <jats:italic toggle=\"yes\">PLCG1<\/jats:italic>\n                      expression, with\n                      <jats:italic toggle=\"yes\">PLCG1<\/jats:italic>\n                      mediating 11.7% of this effect. These findings provide novel insights into pyroptosis regulation in NSCLC and highlight potential therapeutic targets.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050908","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:00:18Z","timestamp":1792173618000},"page":"e50908","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["PLCG1 regulates pyroptosis to inhibit the progression of non-small cell lung cancer"],"prefix":"10.1097","volume":"105","author":[{"given":"Yihui","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, The Affiliated Huizhou Hospital, Guangzhou Medical University, Huizhou, Guangdong, China"},{"name":"Medical College, Shantou University, Shantou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihui","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical College, Shantou University, Shantou, Guangdong, China"},{"name":"Department of Oncology, Huizhou Central People\u2019s Hospital, Huizhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Mo","sequence":"additional","affiliation":[{"name":"Medical College, Shantou University, Shantou, Guangdong, China"},{"name":"Department of Thoracic Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-6905","authenticated-orcid":false,"given":"Jixian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/med.22071","article-title":"Pyroptosis and the fight against lung cancer.","volume":"45","author":"Wang","year":"2025","journal-title":"Med Res Rev"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13046-021-02065-8","article-title":"Pyroptosis at the forefront of anticancer immunity.","volume":"40","author":"Loveless","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics.","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"167245","DOI":"10.1016\/j.jmb.2021.167245","article-title":"Mechanisms and consequences of noncanonical inflammasome-mediated pyroptosis.","volume":"434","author":"Wright","year":"2022","journal-title":"J Mol Biol"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-021-03478-3","article-title":"Gasdermin D pore structure reveals preferential release of mature interleukin-1.","volume":"593","author":"Xia","year":"2021","journal-title":"Nature"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13046-021-01959-x","article-title":"Pyroptosis: a new paradigm of cell death for fighting against cancer.","volume":"40","author":"Tan","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.7150\/thno.71086","article-title":"Pyroptosis in inflammatory diseases and cancer.","volume":"12","author":"Rao","year":"2022","journal-title":"Theranostics"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-020-2079-1","article-title":"A bioorthogonal system reveals antitumour immune function of pyroptosis.","volume":"579","author":"Wang","year":"2020","journal-title":"Nature"},{"key":"R9-20261118","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","article-title":"Role of pyroptosis in inflammation and cancer.","volume":"19","author":"Wei","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10495-021-01703-y","article-title":"Pyroptosis, a target for cancer treatment?","volume":"27","author":"Huang","year":"2022","journal-title":"Apoptosis"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"1043862","DOI":"10.3389\/fonc.2022.1043862","article-title":"Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma.","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41420-021-00557-2","article-title":"Identification of the pyroptosis-related prognostic gene signature and the associated regulation axis in lung adenocarcinoma.","volume":"7","author":"Lin","year":"2021","journal-title":"Cell Death Discov"},{"key":"R14-20261118","first-page":"1971","article-title":"Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR\/Akt signaling and predicts a good prognosis in non-small cell lung cancer.","volume":"40","author":"Gao","year":"2018","journal-title":"Oncol Rep"},{"key":"R15-20261118","first-page":"e1561","article-title":"Expression levels of caspase-3 and gasdermin E and their involvement in the occurrence and prognosis of lung cancer.","volume":"5","author":"Huang","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration.","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR Statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13287-025-04167-y","article-title":"Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases.","volume":"16","author":"Li","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12943-024-02217-2","article-title":"Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance.","volume":"24","author":"Zhao","year":"2025","journal-title":"Mol Cancer"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease.","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat Genet"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank.","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation.","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project.","volume":"45","year":"2013","journal-title":"Nat Genet"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project.","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nbt.3772","article-title":"Toil enables reproducible, open source, big biomedical data analyses.","volume":"35","author":"Vivian","year":"2017","journal-title":"Nat Biotechnol"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"1128358","DOI":"10.3389\/fimmu.2023.1128358","article-title":"Uncoupled pyroptosis and IL-1\u03b2 secretion downstream of inflammasome signaling.","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.pmbts.2025.06.021","article-title":"Pyroptosis and cancer: linking inflammatory cell death to tumorigenesis and therapy.","volume":"217","author":"Pathania","year":"2025","journal-title":"Prog Mol Biol Transl Sci"},{"key":"R33-20261118","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chom.2018.05.009","article-title":"Lipid peroxidation drives gasdermin D-mediated pyroptosis in lethal polymicrobial sepsis.","volume":"24","author":"Kang","year":"2018","journal-title":"Cell Host Microbe"},{"key":"R34-20261118","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature11588","article-title":"The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP.","volume":"492","author":"Lee","year":"2012","journal-title":"Nature"},{"key":"R35-20261118","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes.","volume":"13","author":"Latz","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R36-20261118","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion.","volume":"25","author":"He","year":"2015","journal-title":"Cell Res"},{"key":"R37-20261118","doi-asserted-by":"crossref","first-page":"72167","DOI":"10.18632\/oncotarget.12354","article-title":"A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors.","volume":"7","author":"Gelfo","year":"2016","journal-title":"Oncotarget"},{"key":"R38-20261118","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/imr.12614","article-title":"IL-1 and IL-1 regulatory pathways in cancer progression and therapy.","volume":"281","author":"Mantovani","year":"2018","journal-title":"Immunol Rev"},{"key":"R39-20261118","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"R40-20261118","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ncomms2339","article-title":"Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors.","volume":"3","author":"Rossol","year":"2012","journal-title":"Nat Commun"},{"key":"R41-20261118","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2741\/3385","article-title":"Protein kinase C isoforms: multi-functional regulators of cell life and death.","volume":"14","author":"Reyland","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"R42-20261118","doi-asserted-by":"crossref","first-page":"188619","DOI":"10.1016\/j.bbcan.2021.188619","article-title":"Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis.","volume":"1876","author":"Mandal","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R43-20261118","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin.","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"R44-20261118","doi-asserted-by":"crossref","first-page":"645650","DOI":"10.3389\/fphys.2021.645650","article-title":"Structure, functions, and physiological roles of the lipocalin \u03b11-Microglobulin (A1M).","volume":"12","author":"Bergwik","year":"2021","journal-title":"Front Physiol"},{"key":"R45-20261118","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1357-2725(99)00125-9","article-title":"Bikunin--not just a plasma proteinase inhibitor.","volume":"32","author":"Fries","year":"2000","journal-title":"Int J Biochem Cell Biol"},{"key":"R46-20261118","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/cncr.20034","article-title":"Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer.","volume":"100","author":"Kobayashi","year":"2004","journal-title":"Cancer"},{"key":"R47-20261118","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-2423(07)44007-0","article-title":"Bikunin (urinary trypsin inhibitor): structure, biological relevance, and measurement.","volume":"44","author":"Pugia","year":"2007","journal-title":"Adv Clin Chem"},{"key":"R48-20261118","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signalling orchestrator.","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R49-20261118","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2821","article-title":"Regulation of cell signalling by uPAR.","volume":"11","author":"Smith","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R50-20261118","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ajhg.2011.10.004","article-title":"Abundant pleiotropy in human complex diseases and traits.","volume":"89","author":"Sivakumaran","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R51-20261118","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0167-4838(00)00157-6","article-title":"alpha(1)-Microglobulin: a yellow-brown lipocalin.","volume":"1482","author":"Akerstr\u00f6m","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"R52-20261118","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.10950","article-title":"Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin.","volume":"104","author":"Suzuki","year":"2003","journal-title":"Int J Cancer"},{"key":"R53-20261118","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-94-007-3012-0_3","article-title":"The phospholipase C isozymes and their regulation.","volume":"58","author":"Gresset","year":"2012","journal-title":"Subcell Biochem"},{"key":"R54-20261118","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling.","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R55-20261118","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ajhg.2017.03.004","article-title":"Human demographic history impacts genetic risk prediction across diverse populations.","volume":"100","author":"Martin","year":"2017","journal-title":"Am J Hum Genet"},{"key":"R56-20261118","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","article-title":"The missing diversity in human genetic studies.","volume":"177","author":"Sirugo","year":"2019","journal-title":"Cell"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:00:34Z","timestamp":1794981634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050908"}},"subtitle":["A Mendelian randomization study"],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":56,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050908","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2025-09-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}